Works in Cancer Chemotherapy & Pharmacology, 2008, Vol 62, Issue 5

Results: 26

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Published in:

2008

By:

Ku GY;
Ilson DH;
Schwartz LH;
Capanu M;
O'Reilly E;
Shah MA;
Kelsen DP;
Schwartz GK;
Ku, Geoffrey Y;
Ilson, David H;
Schwartz, Lawrence H;
Capanu, Marinela;
O'Reilly, Eileen;
Shah, Manish A;
Kelsen, David P;
Schwartz, Gary K

Publication type:

journal article

Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.

Published in:

2008

By:

Ji C;
Cao C;
Lu S;
Kivlin R;
Amaral A;
Kouttab N;
Yang H;
Chu W;
Bi Z;
Di W;
Wan Y

Publication type:

Journal Article

Clinical pharmacokinetics of bevacizumab in patients with solid tumors.

Published in:

2008

By:

Lu JF;
Bruno R;
Eppler S;
Novotny W;
Lum B;
Gaudreault J

Publication type:

Journal Article

Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 745, doi. 10.1007/s00280-007-0658-6

By:

Ijichi, Kei;
Adachi, Makoto;
Hasegawa, Yasuhisa;
Ogawa, Tetsuya;
Nakamura, Hideaki;
Kudoh, Ayumi;
Yasui, Yoshihiro;
Murakami, Shingo;
Ishizaki, Kanji

Publication type:

Article

Androgen receptor expression in prostate cancer stem cells: is there a conundrum?

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 921, doi. 10.1007/s00280-007-0659-5

By:

Sharifi, Nima;
Hurt, Elaine M.;
Farrar, William L.

Publication type:

Article

The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 753, doi. 10.1007/s00280-007-0660-z

By:

Bridewell, David J. A.;
Porter, Andrew C. G.;
Finlay, Graeme J.;
Baguley, Bruce C.

Publication type:

Article

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 763, doi. 10.1007/s00280-007-0661-y

By:

Hong Suk Song;
Young Rok Do;
Heung Moon Chang;
Min Hee Ryu;
Kyung Hee Lee;
Yeul Hong Kim;
Dae Sik Hong;
Jae Yong Cho;
Kyoung Eun Lee;
Si Young Kim

Publication type:

Article

An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 769, doi. 10.1007/s00280-007-0662-x

By:

Banerji, Udai;
Sain, Nivedita;
Sharp, Swee Y.;
Valenti, Melanie;
Asad, Yasmin;
Ruddle, Ruth;
Raynaud, Florence;
Walton, Michael;
Eccles, Suzanne A.;
Judson, Ian;
Jackman, Ann L.;
Workman, Paul

Publication type:

Article

Clinical pharmacokinetics of bevacizumab in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 779, doi. 10.1007/s00280-007-0664-8

By:

Jian-Feng Lu;
Bruno, Rene;
Eppler, Steve;
Novotny, William;
Lum, Bert;
Gaudreault, Jacques

Publication type:

Article

Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 787, doi. 10.1007/s00280-007-0666-6

By:

Wietrzyk, Joanna;
Nevozhay, Dmitry;
Milczarek, Magdalena;
Filip, Beata;
Kutner, Andrzej

Publication type:

Article

7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 799, doi. 10.1007/s00280-007-0667-5

By:

Tzu-Sheng Hsu;
Chinpiao Chen;
Pei-Ting Lee;
Shu-Jun Chiu;
Huei-Fang Liu;
Chih-Chien Tsai;
Jui-I Chao

Publication type:

Article

Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 811, doi. 10.1007/s00280-007-0668-4

By:

de Heer, Pieter;
Sandel, Maro H.;
Guertens, Gunther;
de Boeck, Gert;
Koudijs, Margaretha M.;
Nagelkerke, J. Fred;
Junggeburt, Jan M. C.;
de Bruijn, Ernst A.;
van deVelde, Cornelis J. H.;
Kuppen, Peter J. K.

Publication type:

Article

Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 821, doi. 10.1007/s00280-007-0669-3

By:

Munkelt, Doreen;
Koehl, Ulrike;
Kloess, Stephan;
Zimmermann, Stefanie-Yvonne;
ElKalaäoui, Rabiá;
Wehner, Sibylle;
Schwabe, Dirk;
Lehrnbecher, Thomas;
Schubert, Ralf;
Kreuter, Joerg;
Klingebiel, Thomas;
Esser, Ruth

Publication type:

Article

2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 831, doi. 10.1007/s00280-007-0670-x

By:

Kar, Siddhartha;
Meifang Wang;
Carr, Brian I.

Publication type:

Article

Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 841, doi. 10.1007/s00280-007-0671-9

By:

Heijns, Joan B.;
van der Burg, Maria E. L.;
van Gelder, Teun;
Fieren, Marien W. J. A.;
de Bruijn, Peter;
van der Gaast, Ate;
Loos, Walter J.

Publication type:

Article

Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 911, doi. 10.1007/s00280-007-0672-8

By:

Rodon, Jordi;
Garrison, Mitchell;
Hammond, Lisa A.;
de Bono, Johann;
Smith, Lon;
Forero, Leonardo;
Hao, Desirée;
Takimoto, Chris;
Lambert, John M.;
Pandite, Lini;
Howard, Maria;
Hongsheng Xie;
Tolcher, Anthony W.

Publication type:

Article

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 849, doi. 10.1007/s00280-007-0673-7

By:

Furuse, Junji;
Okusaka, Takuji;
Boku, Narikazu;
Ohkawa, Shinichi;
Sawaki, Akira;
Masumoto, Toshikazu;
Funakoshi, Akihiro

Publication type:

Article

Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 857, doi. 10.1007/s00280-007-0674-6

By:

Chao Ji;
Cong Cao;
Shan Lu;
Kivlin, Rebecca;
Amaral, Ashley;
Kouttab, Nicola;
Hui Yang;
Wenming Chu;
Zhigang Bi;
Wen Di;
Yinsheng Wan

Publication type:

Article

Oxaliplatin-induced immune mediated thrombocytopenia.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 925, doi. 10.1007/s00280-007-0675-5

By:

Beg, Muhammad S.;
Komrokji, Rami S.;
Ahmed, Kashif;
Safa, Malek M.

Publication type:

Article

Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 867, doi. 10.1007/s00280-007-0676-4

By:

Nabekura, Tomohiro;
Yamaki, Takeshi;
Ueno, Kazuyuki;
Kitagawa, Shuji

Publication type:

Article

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 875, doi. 10.1007/s00280-008-0677-y

By:

Ku, Geoffrey Y.;
Ilson, David H.;
Schwartz, Lawrence H.;
Capanu, Marinela;
O'Reilly, Eileen;
Shah, Manish A.;
Kelsen, David P.;
Schwartz, Gary K.

Publication type:

Article

2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 893, doi. 10.1007/s00280-008-0679-9

By:

Azab, Samar S.;
Salama, Salama A.;
Hassan, Memy H.;
Khalifa, Amani E.;
El-Demerdash, Ebtehal;
Fouad, Hala;
Al-Hendy, Ayman;
Abdel-Naim, Ashraf B.

Publication type:

Article

Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin.

Published in:

2008

By:

Kampitak, Thatchai

Publication type:

Letter

Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 903, doi. 10.1007/s00280-008-0682-1

By:

Bartsch, Rupert;
Wenzel, Catharina;
Gampenrieder, Simon P.;
Pluschnig, Ursula;
Altorjai, Gabriela;
Rudas, Margaretha;
Mader, Robert M.;
Dubsky, Peter;
Rottenfusser, Andrea;
Gnant, Michael;
Zielinski, Christoph C.;
Steger, Guenther G.

Publication type:

Article

7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.

Published in:

2008

By:

Hsu, Tzu-Sheng;
Chen, Chinpiao;
Lee, Pei-Ting;
Chiu, Shu-Jun;
Liu, Huei-Fang;
Tsai, Chih-Chien;
Chao, Jui-I

Publication type:

Correction Notice

In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 881, doi. 10.1007/s00280-008-0678-x

By:

Rassnick, Kenneth M.;
Muindi, Josephia R.;
Johnson, Candace S.;
Balkman, Cheryl E.;
Ramnath, Nithya;
Wei-Dong Yu;
Engler, Kristie L.;
Page, Rodney L.;
Trump, Donald L.

Publication type:

Article